Literature DB >> 2512827

Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men.

S M Wolinsky1, C R Rinaldo, S Kwok, J J Sninsky, P Gupta, D Imagawa, H Farzadegan, L P Jacobson, K S Grovit, M H Lee.   

Abstract

STUDY
OBJECTIVE: To study the natural history of human immunodeficiency virus type 1 (HIV-1) infection, we used an in-vitro amplification technique to detect HIV-1 nucleic acid sequences in sequential aliquots of peripheral blood mononuclear cells from homosexual men enrolled in the Multicenter AIDS Cohort Study. DESIGN AND PATIENTS: Blinded, longitudinal study of 24 homosexual men who were positive for HIV-1 antibodies at a recent follow-up visit.
MEASUREMENTS AND MAIN RESULTS: Coded clinical samples were evaluated using two enzyme-linked immunosorbent assays (whole virus and gp120-gp41 fragment), Western blot, a p24 antigen capture assay, virus cocultivation, and in-vitro amplification of conserved regions from the HIV-1 gag and env open-reading frames. In 20 of the 24 men an HIV-1 enzymatically amplified product was detected before HIV-1 antibody seroconversion: at 42 months before seroconversion in two cases; at 36 months in one case; at 30 months in one case; at 24 months in four cases; at 18 months in eight cases; at 12 months in one case; and at 6 months in three cases (median, 18 months). In the four other men, detection of an HIV-1 enzymatically amplified product was concurrent with confirmation of antibody seroconversion by Western blot.
CONCLUSIONS: There is a long and variable interval between virus acquisition and a diagnostic serum antibody response, perhaps due to the prolonged, persistent infection characteristic of the lentiviruses (family Retroviridae).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512827     DOI: 10.7326/0003-4819-111-12-961

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 2.  Transmission of hepatitis and AIDS: risks for the anaesthetist and the patient.

Authors:  C A Trépanier
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

3.  Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection.

Authors:  L Romano; M Catucci; A De Milito; G Venturi; M Zazzi; P Almi; A Gonnelli; M Rubino; R Maestrini; P E Valensin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

4.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

5.  Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1.

Authors:  A J Whetsell; J B Drew; G Milman; R Hoff; E A Dragon; K Adler; J Hui; P Otto; P Gupta; H Farzadegan
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

Review 6.  More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.

Authors:  S Hashida; K Hashinaka; S Ishikawa; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

7.  Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.

Authors:  T Jehuda-Cohen; B A Slade; J D Powell; F Villinger; B De; T M Folks; H M McClure; K W Sell; A Ahmed-Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Prospective multicenter study on isolation of human immunodeficiency virus type 1 from homosexual men after seroconversion.

Authors:  P Gupta; H Farzadegan; D Imagawa; M Lee; L Kingsley; S Zhou; J Armstrong; C Rinaldo
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Fatal HIV encephalitis in HIV-seronegative patients.

Authors:  Troy M Martin; Josiah D Rich
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.